반응식
[O:1]([C:8]1[CH:9]=[C:10]([C@@H:14]2[CH2:18][CH2:17][CH2:16][NH:15]2)[CH:11]=[CH:12][CH:13]=1)[C:2]1[CH:7]=[CH:6][CH:5]=[CH:4][CH:3]=1.[CH3:19][C:20]([O:23][C:24]([NH:26][C@H:27]([C:34](O)=[O:35])[CH:28]1[CH2:33][CH2:32][CH2:31][CH2:30][CH2:29]1)=[O:25])([CH3:22])[CH3:21].C1C=CC2N(O)N=NC=2C=1.CN(C(ON1N=NC2C=CC=CC1=2)=[N+](C)C)C.F[P-](F)(F)(F)(F)F.CCN(C(C)C)C(C)C>CN(C=O)C.[Cl-].[Na+].O>[C:20]([O:23][C:24](=[O:25])[NH:26][C@@H:27]([CH:28]1[CH2:29][CH2:30][CH2:31][CH2:32][CH2:33]1)[C:34](=[O:35])[N:15]1[CH2:16][CH2:17][CH2:18][C@H:14]1[C:10]1[CH:11]=[CH:12][CH:13]=[C:8]([O:1][C:2]2[CH:3]=[CH:4][CH:5]=[CH:6][CH:7]=2)[CH:9]=1)([CH3:22])([CH3:19])[CH3:21]참가 물질
8
반응물 5
생성물 1
시약·촉매·용매 2
실험 절차
(S)-2-(3-phenoxy-phenyl)-pyrrolidine (1.2 g, 5.02 mmol) is added to a solution of Boc-L-α-cyclohexylglycine (1.42 g, 5.2 mmol), HOBt (1.0 g, 7.53 mmol) and HBTU (2.86 g, 7.53 mmol) in 10 mL of DMF. Hunig's base (3.6 MI, 20 mmol) is added and the mixture is stirred for 30 minutes. The mixture is diluted with brine (20 mL) and extracted with EtOAc (3×10 mL). The organics were combined, dried over Na2SO4, filtered, concentrated under reduced pressures and purified by silica gel column chromatography (20% EtOAc/Hexanes) to give {(S)-1-cyclohexyl-2-oxo-2-[(S)-2-(3-phenoxy-phenyl)-pyrrolidine-1-yl]-ethyl}-cabamic acid tert-butyl ester as a white powder (1.65 g, 66%). LCMS m/z 479.2 (M+1).
후처리
- extractionextracted with EtOAc (3×10 mL)
- dry with materialdried over Na2SO4
- filtrationfiltered
- concentrationconcentrated under reduced pressures
- custompurified by silica gel column chromatography (20% EtOAc/Hexanes)
- customto give {(S)-1-cyclohexyl-2-oxo-2-[(S)-2-(3-phenoxy-phenyl)-pyrrolidine-1-yl]-ethyl}-cabamic acid tert-butyl ester as a white powder (1.65 g, 66%)
출처 및 근거
- ORD 기록
- ord-3b7976df8fac4d43b0fc9f16cd0c9357
- 출처 데이터셋
- uspto-grants-2012_12
- 특허 번호
- US08338440B2
연결된 노트
불러오는 중…